Inventor

Richard A. Berg

Inventor
Los Altos, CA, US

Overview

50→
Patents
1987–2017
Patent span
Chemistry
Primary field (CPC C)

Patents· 50 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Lprimary
A61LMethods or apparatus for sterilising materials or objects in general13%
C08LCompositions of macromolecular compounds12%
A61KPreparations for medical, dental or toiletry purposes9%
C08BPolysaccharides9%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests9%
C08HDerivatives of natural macromolecular compounds8%
A61FFilters implantable into blood vessels7%
C07KPeptides6%
C12NMicroorganisms or enzymes5%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds4%
PatentTitleYear
9,682,167'Carboxymethylcellulose polyethylene glycol compositions for medical uses'20179,381,271'Carboxymethylcellulose polyethylene glycol compositions for medical uses'20169,345,809'Carboxymethylcellulose polyethylene glycol compositions for medical uses'20169,161,987'Carboxymethylcellulose polyethylene glycol compositions for medical uses'20158,197,802'Method for treating or inhibiting the formation of adhesions following surgery or injury'20127,883,694'Method for preventing the formation of adhesions following surgery or injury'20117,192,984'Compositions of polyacids and polyethers and methods for their use as dermal fillers'20077,176,256'Biocompatible crosslinked composition'20077,151,135'Crosslinked polymer compositions'20066,969,400'Synthetic implant with nonimmunogenicity coating'20056,923,961'Chemically activated carboxypolysaccharides and methods for use to inhibit adhesion formation and promote hemostasis'20056,911,496'Composition for administration of a biologically active compound'20056,713,662'Production of collagen in the milk of transgenic mammals'20046,653,450'Mutated recombinant collagens'20036,534,591'Cross-linked polymer compositions and methods for their use'20036,472,171'Expression of procollagen in yeast'20026,323,278'Method of making crosslinked polymer matrices in tissue treatment applications'20016,165,489'Crosslinked collagen compositions for in situ administration'20006,166,130'Method of using crosslinked polymer compositions in tissue treatment applications'20006,111,165'Production of human recombinant collagen in the milk of transgenic animals'20006,051,648'Crosslinked polymer compositions and methods for their use'20005,962,648'Production of human recombinant collagen in the milk of transgenic mammals'19995,945,101'Skin model system'19995,895,833'Production of human recombinant collagen in the milk of transgenic animals'19995,888,248'Dermal-epidermal in vitro test system'19995,874,500'Crosslinked polymer compositions and methods for their use'19995,807,581'Collagen-based injectable drug delivery system and its use'19985,800,541'Collagen-synthetic polymer matrices prepared using a multiple step reaction'19985,755,814'Dermal-epidermal in vitro test system'19985,752,974'Injectable or implantable biomaterials for filling or blocking lumens and voids of the body'19985,667,839'Human recombinant collagen in the milk of transgenic animals'19975,643,464'Process for preparing a sterile, dry crosslinking agent'19975,550,187'Method of preparing crosslinked biomaterial compositions for use in tissue augmentation'19965,527,856'Method of preparing crosslinked biomaterial compositions for use in tissue augmentation'19965,510,121'Glycosaminoglycan-synthetic polymer conjugates'19965,510,418'Glycosaminoglycan-synthetic polymer conjugates'19965,476,666'Glycosaminoglycan-synthetic polymer conjugates'19955,475,052'Collagen-synthetic polymer matrices prepared using a multiple step reaction'19955,470,911'Glycosaminoglycan-synthetic polymer conjugates'19955,196,196'Use of protease nexin-I in wound dressings'19935,112,608'Use of protease nexin-I to mediate wound healing'19924,997,753'Weighted collagen microsponge for immobilizing bioactive material'19914,971,954'Collagen-based matrices ribose cross-linked'19904,970,298'Biodegradable matrix and methods for producing same'19904,925,924'Biocompatible synthetic and collagen compositions having a dual-type porosity for treatment of wounds and pressure ulcers and therapeutic methods thereof'19904,863,856'Weighted collagen microsponge for immobilizing bioactive materials'19894,861,714'Weighted collagen microsponge for immobilizing bioactive material'19894,841,962'Collagen matrix/polymer film composite dressing'19894,837,285'Collagen matrix beads for soft tissue repair'19894,703,108'Biodegradable matrix and methods for producing same'1987

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1987–1990Patents assigned to UNIV NEW JERSEY MED (4)· patent assignee history
1987–1999Based in Lambertville, NJ, US· patent location history
1989–2016Patents assigned to BERG RICHARD A (3)· patent assignee history
1995–1998Patents assigned to COLLAGEN CORP (11)· patent assignee history
1995–2012Based in Los Altos, CA, US· patent location history
1997Based in Sunnyvale, CA, US· patent location history
1999–2005Patents assigned to COHESION TECH INC (13)· patent assignee history
2000Based in Palo Alto, CA, US· patent location history
2005–2017Patents assigned to FZIOMED INC (6)· patent assignee history
2005–2017Based in Arroyo Grande, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
COHESION TECH INC131999–2005
COLLAGEN CORP111995–1998
FZIOMED INC62005–2017
UNIV NEW JERSEY MED41987–1990
BERG RICHARD Aself31989–2016
Locations
LocationPatentsSpan
Los Altos, California, US281995–2012
Lambertville, New Jersey, US141987–1999
Arroyo Grande, California, US62005–2017
Palo Alto, California, US12000
Sunnyvale, California, US11997